The Misleading "Pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19).
Imad M TleyjehPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)